EUPRAXIA PHARMACEUTICALS INC (EPRX.CA) Stock Analyst Ratings
Canada - TSX:EPRX - CA29842P1053 - Common Stock
7.35 CAD
-0.22 (-2.91%)
ChartMill assigns a Buy % Consensus number of 84% to EPRX.CA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 11.22. This target is 52.65% above the current price.
EPRX.CA was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about EPRX.CA.
In the previous month the buy percentage consensus was at a similar level.
EPRX.CA was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-11-08 | Canaccord Capital | Downgrade | Buy |
| 2022-11-01 | Raymond James Capital | Upgrade | Outperform |
| 2022-06-09 | Raymond James Capital | Initiate | Outperform |
| 2022-04-21 | Canaccord Capital | Downgrade | Buy |
| 2022-04-01 | Raymond James Capital | Initiate | Outperform |
| 2021-11-12 | RaymondJamesFinancial | Downgrade | Outperform |
| 2021-08-18 | Canaccord Genuity | Downgrade | Buy |
| 2021-08-17 | Raymond James Financial | Initiate | Outperform |